{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T07:48:43Z","timestamp":1781250523810,"version":"3.54.1"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T00:00:00Z","timestamp":1762560000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T00:00:00Z","timestamp":1762560000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["F31NS139652"],"award-info":[{"award-number":["F31NS139652"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R01NS121294"],"award-info":[{"award-number":["R01NS121294"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Neuropathol"],"DOI":"10.1007\/s00401-025-02957-5","type":"journal-article","created":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T17:14:30Z","timestamp":1762622070000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Co-infection with two \u03b1-synuclein strains reveals novel synergistic interactions"],"prefix":"10.1007","volume":"150","author":[{"given":"Sara A. M.","family":"Holec","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chase R.","family":"Khedmatgozar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shelbe J.","family":"Schure","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason C.","family":"Bartz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda L.","family":"Woerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,8]]},"reference":[{"issue":"6645","key":"2957_CR1","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/42166","volume":"388","author":"MG Spillantini","year":"1997","unstructured":"Spillantini MG, Schmidt ML, Lee VM-Y, Trojanowski JQ, Jakes R, Goedert M (1997) \u03b1-Synuclein in Lewy bodies. Nature 388(6645):839\u2013840","journal-title":"Nature"},{"issue":"11","key":"2957_CR2","doi-asserted-by":"publisher","first-page":"6469","DOI":"10.1073\/pnas.95.11.6469","volume":"95","author":"MG Spillantini","year":"1998","unstructured":"Spillantini MG, Crowther RA, Jakes R, Hasegawa M, Goedert M (1998) \u03b1-Synuclein in filamentous inclusions of Lewy bodies from Parkinson\u2019s disease and dementia with Lewy bodies. Proc Natl Acad Sci USA 95(11):6469\u20136473","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"2957_CR3","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/S0304-3940(98)00504-7","volume":"251","author":"MG Spillantini","year":"1998","unstructured":"Spillantini MG, Crowther RA, Jakes R, Cairns NJ, Lantos PL, Goedert M (1998) Filamentous \u03b1-synuclein inclusions link multiple system atrophy with Parkinson\u2019s disease and dementia with Lewy bodies. Neurosci Lett 251(3):205\u2013208","journal-title":"Neurosci Lett"},{"issue":"2\u20133","key":"2957_CR4","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/S0304-3940(98)00407-8","volume":"249","author":"K Wakabayashi","year":"1998","unstructured":"Wakabayashi K, Yoshimoto M, Tsuji S, Takahashi H (1998) \u03b1-Synuclein immunoreactivity in glial cytoplasmic inclusions in multiple system atrophy. Neurosci Lett 249(2\u20133):180\u2013182","journal-title":"Neurosci Lett"},{"key":"2957_CR5","doi-asserted-by":"publisher","first-page":"2096","DOI":"10.1128\/jvi.66.4.2096-2101.1992","volume":"66","author":"RA Bessen","year":"1992","unstructured":"Bessen RA, Marsh RF (1992) Biochemical and physical properties of the prion protein from two strains of the transmissible mink encephalopathy agent. J Virol 66:2096\u20132101","journal-title":"J Virol"},{"issue":"2","key":"2957_CR6","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1099\/0022-1317-73-2-329","volume":"73","author":"RA Bessen","year":"1992","unstructured":"Bessen RA, Marsh RF (1992) Identification of two biologically distinct strains of transmissible mink encephalopathy in hamsters. J Gen Virol 73(2):329\u2013334","journal-title":"J Gen Virol"},{"issue":"1","key":"2957_CR7","doi-asserted-by":"publisher","first-page":"e1011920","DOI":"10.1371\/journal.ppat.1011920","volume":"20","author":"CR Khedmatgozar","year":"2024","unstructured":"Khedmatgozar CR, Holec SAM, Woerman AL (2024) The role of \u03b1-synuclein prion strains in Parkinson\u2019s disease and multiple system atrophy. PLoS Pathog 20(1):e1011920","journal-title":"PLoS Pathog"},{"issue":"7825","key":"2957_CR8","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1038\/s41586-020-2317-6","volume":"585","author":"M Schweighauser","year":"2020","unstructured":"Schweighauser M, Shi Y, Tarutani A, Kametani F, Murzin AG, Ghetti B et al (2020) Structures of \u03b1-synuclein filaments from multiple system atrophy. Nature 585(7825):464\u2013469","journal-title":"Nature"},{"issue":"7933","key":"2957_CR9","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1038\/s41586-022-05319-3","volume":"610","author":"Y Yang","year":"2022","unstructured":"Yang Y, Shi Y, Schweighauser M, Zhang X, Kotecha A, Murzin AG et al (2022) Structures of alpha-synuclein filaments from human brains with Lewy pathology. Nature 610(7933):791\u2013795","journal-title":"Nature"},{"key":"2957_CR10","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1186\/s40478-025-02093-x","volume":"13","author":"SAM Holec","year":"2025","unstructured":"Holec SAM, Lee J, Khedmatgozar CR, Wojewska MJ, Oehler A, Halliday GM et al (2025) Evidence of a novel alpha-synuclein strain isolated from a Parkinson\u2019s disease with dementia patient sample. Acta Neuropathol Commun 13:177","journal-title":"Acta Neuropathol Commun"},{"key":"2957_CR11","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/S1474-4422(05)70225-8","volume":"4","author":"M Polymenidou","year":"2005","unstructured":"Polymenidou M, Stoeck K, Glatzel M, Vey M, Bellon A, Aguzzi A (2005) Coexistence of multiple PrPSc types in individuals with Creutzfeldt-Jakob disease. Lancet Neurol 4:805\u2013814","journal-title":"Lancet Neurol"},{"issue":"Pt 10","key":"2957_CR12","doi-asserted-by":"publisher","first-page":"2643","DOI":"10.1093\/brain\/awp196","volume":"132","author":"I Cali","year":"2009","unstructured":"Cali I, Castellani R, Alshekhlee A, Cohen Y, Blevins J, Yuan J et al (2009) Co-existence of scrapie prion protein types 1 and 2 in sporadic Creutzfeldt-Jakob disease: its effect on the phenotype and prion-type characteristics. Brain 132(Pt 10):2643\u20132658","journal-title":"Brain"},{"key":"2957_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-58446-0","author":"I Cali","year":"2020","unstructured":"Cali I, Puoti G, Smucny J, Curtiss PM, Cracco L, Kitamoto T et al (2020) Co-existence of PrPD types 1 and 2 in sporadic Creutzfeldt-Jakob disease of the VV subgroup: phenotypic and prion protein characteristics. Sci Rep. https:\/\/doi.org\/10.1038\/s41598-020-58446-0","journal-title":"Sci Rep"},{"issue":"77","key":"2957_CR14","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1038\/newbio237244a0","volume":"237","author":"AG Dickinson","year":"1972","unstructured":"Dickinson AG, Fraser H, Meikle VMH, Outram GW (1972) Competition between different scrapie agents in mice. Nat New Biol 237(77):244\u2013245","journal-title":"Nat New Biol"},{"issue":"5492","key":"2957_CR15","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1038\/253556a0","volume":"253","author":"AG Dickinson","year":"1975","unstructured":"Dickinson AG, Fraser H, McConnell I, Outram GW, Sales DI, Taylor DM (1975) Extraneural competition between different scrapie agents leading to loss of infectivity. Nature 253(5492):556","journal-title":"Nature"},{"issue":"2","key":"2957_CR16","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1159\/000149588","volume":"23","author":"RH Kimberlin","year":"1985","unstructured":"Kimberlin RH, Walker CA (1985) Competition between strains of scrapie depends on the blocking agent being infectious. Intervirology 23(2):74\u201381","journal-title":"Intervirology"},{"key":"2957_CR17","doi-asserted-by":"publisher","first-page":"5542","DOI":"10.1128\/JVI.74.12.5542-5547.2000","volume":"74","author":"JC Bartz","year":"2000","unstructured":"Bartz JC, Bessen RA, McKenzie D, Marsh RF, Aiken JM (2000) Adaptation and selection of prion protein strain conformations following interspecies transmission of transmissible mink encephalopathy. J Virol 74:5542\u20135547","journal-title":"J Virol"},{"issue":"Pt 1","key":"2957_CR18","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1099\/vir.0.19394-0","volume":"85","author":"JC Bartz","year":"2004","unstructured":"Bartz JC, Aiken JM, Bessen RA (2004) Delay in onset of prion disease for the HY strain of transmissible mink encephalopathy as a result of prior peripheral inoculation with the replication-deficient DY strain. J Gen Virol 85(Pt 1):265\u2013273","journal-title":"J Gen Virol"},{"issue":"2","key":"2957_CR19","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1128\/JVI.01751-06","volume":"81","author":"JC Bartz","year":"2007","unstructured":"Bartz JC, Kramer ML, Sheehan MH, Hutter JA, Ayers JI, Bessen RA et al (2007) Prion interference is due to a reduction in strain-specific PrPSc levels. J Virol 81(2):689\u2013697","journal-title":"J Virol"},{"issue":"12","key":"2957_CR20","doi-asserted-by":"publisher","first-page":"5715","DOI":"10.1128\/JVI.00409-16","volume":"90","author":"KA Langenfeld","year":"2016","unstructured":"Langenfeld KA, Shikiya RA, Kincaid AE, Bartz JC (2016) Incongruity between prion conversion and incubation period following coinfection. J Virol 90(12):5715\u20135723","journal-title":"J Virol"},{"issue":"4","key":"2957_CR21","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1007\/s00401-022-02476-7","volume":"144","author":"SAM Holec","year":"2022","unstructured":"Holec SAM, Lee J, Oehler A, Ooi FK, Mordes DA, Olson SH et al (2022) Multiple system atrophy prions transmit neurological disease to mice expressing wild-type human \u03b1-synuclein. Acta Neuropathol 144(4):677\u2013690","journal-title":"Acta Neuropathol"},{"issue":"12","key":"2957_CR22","doi-asserted-by":"publisher","first-page":"e1010956","DOI":"10.1371\/journal.ppat.1010956","volume":"18","author":"SAM Holec","year":"2022","unstructured":"Holec SAM, Lee J, Oehler A, Batia L, Wiggins-Gamble A, Lau J et al (2022) The E46K mutation modulates \u03b1-synuclein prion replication in transgenic mice. PLoS Pathog 18(12):e1010956","journal-title":"PLoS Pathog"},{"issue":"12","key":"2957_CR23","doi-asserted-by":"publisher","first-page":"e1012746","DOI":"10.1371\/journal.ppat.1012746","volume":"20","author":"SAM Holec","year":"2024","unstructured":"Holec SAM, Khedmatgozar CR, Schure SJ, Pham T, Woerman AL (2024) A-synuclein prion strains differentially adapt after passage in mice. PLoS Pathog 20(12):e1012746","journal-title":"PLoS Pathog"},{"issue":"2","key":"2957_CR24","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1073\/pnas.1719369115","volume":"115","author":"AL Woerman","year":"2018","unstructured":"Woerman AL, Kazmi SA, Patel S, Aoyagi A, Oehler A, Widjaja K et al (2018) Familial Parkinson\u2019s point mutation abolishes multiple system atrophy prion replication. Proc Natl Acad Sci USA 115(2):409\u2013414","journal-title":"Proc Natl Acad Sci USA"},{"issue":"35","key":"2957_CR25","doi-asserted-by":"publisher","first-page":"E4949","DOI":"10.1073\/pnas.1513426112","volume":"112","author":"AL Woerman","year":"2015","unstructured":"Woerman AL, St\u00f6hr J, Aoyagi A, Rampersaud R, Krejciova Z, Watts JC et al (2015) Propagation of prions causing synucleinopathies in cultured cells. Proc Natl Acad Sci U S A 112(35):E4949\u2013E4958","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"2957_CR26","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.3233\/JPD-240296","volume":"14","author":"PM Reis","year":"2024","unstructured":"Reis PM, Holec SAM, Ezeiruaku C, Frost MP, Brown CK, Liu SL et al (2024) Structurally targeted mutagenesis identifies key residues supporting \u03b1-synuclein misfolding in multiple system atrophy. J Parkinsons Dis 14(8):1543\u20131558","journal-title":"J Parkinsons Dis"},{"issue":"4","key":"2957_CR27","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/S0896-6273(02)00682-7","volume":"34","author":"BI Giasson","year":"2002","unstructured":"Giasson BI, Duda JE, Quinn SM, Zhang B, Trojanowski JQ, Lee VM (2002) Neuronal \u03b1-synucleinopathy with severe movement disorder in mice expressing A53T human \u03b1-synuclein. Neuron 34(4):521\u2013533","journal-title":"Neuron"},{"key":"2957_CR28","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/0092-8674(86)90875-5","volume":"46","author":"GA Carlson","year":"1986","unstructured":"Carlson GA, Kingsbury DT, Goodman PA, Coleman S, Marshall ST, DeArmond S et al (1986) Linkage of prion protein and scrapie incubation time genes. Cell 46:503\u2013511","journal-title":"Cell"},{"key":"2957_CR29","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/0021-9975(73)90022-4","volume":"83","author":"AG Dickinson","year":"1973","unstructured":"Dickinson AG, Outram GW (1973) Differences in access into the central nervous system of ME7 scrapie agent from two strains of mice. J Comp Pathol 83:13\u201318","journal-title":"J Comp Pathol"},{"key":"2957_CR30","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1038\/256732a0","volume":"256","author":"AG Dickinson","year":"1975","unstructured":"Dickinson AG, Fraser H, Outram GW (1975) Scrapie incubation time can exceed natural lifespan. Nature 256:732\u2013733","journal-title":"Nature"},{"issue":"11","key":"2957_CR31","doi-asserted-by":"publisher","first-page":"5706","DOI":"10.1128\/JVI.00243-10","volume":"84","author":"RA Shikiya","year":"2010","unstructured":"Shikiya RA, Ayers JI, Schutt CR, Kincaid AE, Bartz JC (2010) Coinfecting prion strains compete for a limiting cellular resource. J Virol 84(11):5706\u20135714","journal-title":"J Virol"},{"issue":"38","key":"2957_CR32","doi-asserted-by":"publisher","first-page":"E5308","DOI":"10.1073\/pnas.1514475112","volume":"112","author":"SB Prusiner","year":"2015","unstructured":"Prusiner SB, Woerman AL, Mordes DA, Watts JC, Rampersaud R, Berry DB et al (2015) Evidence for \u03b1-synuclein prions causing multiple system atrophy in humans with parkinsonism. Proc Natl Acad Sci USA 112(38):E5308\u2013E5317","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"2957_CR33","doi-asserted-by":"publisher","first-page":"e1008222","DOI":"10.1371\/journal.ppat.1008222","volume":"16","author":"AL Woerman","year":"2020","unstructured":"Woerman AL, Patel S, Kazmi SA, Oehler A, Lee J, Mordes DA et al (2020) Kinetics of \u03b1-synuclein prions preceding neuropathological inclusions in multiple system atrophy. PLoS Pathog 16(2):e1008222","journal-title":"PLoS Pathog"},{"key":"2957_CR34","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/S0006-291X(84)80190-4","volume":"120","author":"GG Glenner","year":"1984","unstructured":"Glenner GG, Wong CW (1984) Alzheimer\u2019s disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Commun 120:885\u2013890","journal-title":"Biochem Biophys Res Commun"},{"key":"2957_CR35","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1038\/325733a0","volume":"325","author":"J Kang","year":"1987","unstructured":"Kang J, Lemaire H-G, Unterbeck A, Salbaum JM, Masters CL, Grzeschik K-H et al (1987) The precursor of Alzheimer\u2019s disease amyloid A4 protein resembles a cell-surface receptor. Nature 325:733\u2013736","journal-title":"Nature"},{"key":"2957_CR36","first-page":"229","volume":"95","author":"J-P Brion","year":"1985","unstructured":"Brion J-P, Passareiro H, Nunez J, Flament-Durand J (1985) Mise en \u00e9vidence immunologique de la prot\u00e9ine tau au niveau des l\u00e9sions de d\u00e9g\u00e9n\u00e9rescence neurofibrillaire de la maladie d\u2019Alzheimer. Arch Biol 95:229\u2013235","journal-title":"Arch Biol"},{"key":"2957_CR37","doi-asserted-by":"publisher","first-page":"4051","DOI":"10.1073\/pnas.85.11.4051","volume":"85","author":"M Goedert","year":"1988","unstructured":"Goedert M, Wischik CM, Crowther RA, Walker JE, Klug A (1988) Cloning and sequencing of the cDNA encoding a core protein of the paired helical filament of Alzheimer disease: identification as the microtubule-associated protein tau. Proc Natl Acad Sci USA 85:4051\u20134055","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"2957_CR38","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s00401-017-1709-7","volume":"134","author":"TL Spires-Jones","year":"2017","unstructured":"Spires-Jones TL, Attems J, Thal DR (2017) Interactions of pathological proteins in neurodegenerative diseases. Acta Neuropathol 134(2):187\u2013205","journal-title":"Acta Neuropathol"},{"issue":"3","key":"2957_CR39","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1017\/cjn.2022.34","volume":"50","author":"SL Forrest","year":"2023","unstructured":"Forrest SL, Kovacs GG (2023) Current concepts of mixed pathologies in neurodegenerative diseases. Can J Neurol Sci 50(3):329\u2013345","journal-title":"Can J Neurol Sci"},{"issue":"10","key":"2957_CR40","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1002\/mds.29897","volume":"39","author":"J Burr\u00e9","year":"2024","unstructured":"Burr\u00e9 J, Edwards RH, Halliday G, Lang AE, Lashuel HA, Melki R et al (2024) Research priorities on the role of \u03b1-synuclein in Parkinson\u2019s disease pathogenesis. Mov Disord 39(10):1663\u20131678","journal-title":"Mov Disord"},{"issue":"3","key":"2957_CR41","doi-asserted-by":"publisher","first-page":"e70021","DOI":"10.1111\/jnc.70021","volume":"169","author":"E Szegvari","year":"2025","unstructured":"Szegvari E, Holec SAM, Woerman AL (2025) Limitations and applications of rodent models in tauopathy and synucleinopathy research. J Neurochem 169(3):e70021","journal-title":"J Neurochem"},{"issue":"1","key":"2957_CR42","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s40478-025-01944-x","volume":"13","author":"M Otero-Jimenez","year":"2025","unstructured":"Otero-Jimenez M, Wojeska MJ, Binding LP, Jogaudaite S, Gray-Rodriguez S, Young AL et al (2025) Neuropathological stages of neuronal, astrocytic and oligodendrocytic alpha-synuclein pathology in Parkinson\u2019s disease. Acta Neuropathol Commun 13(1):25","journal-title":"Acta Neuropathol Commun"},{"issue":"1","key":"2957_CR43","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1128\/JVI.01745-08","volume":"83","author":"JI Ayers","year":"2009","unstructured":"Ayers JI, Kincaid AE, Bartz JC (2009) Prion strain targeting independent of strain-specific neuronal tropism. J Virol 83(1):81\u201387","journal-title":"J Virol"},{"issue":"47","key":"2957_CR44","doi-asserted-by":"publisher","first-page":"20051","DOI":"10.1073\/pnas.0908005106","volume":"106","author":"KC Luk","year":"2009","unstructured":"Luk KC, Song C, O\u2019Brien P, Stieber A, Branch JR, Brunden KR et al (2009) Exogenous alpha-synuclein fibrils seed the formation of Lewy body-like intracellular inclusions in cultured cells. Proc Natl Acad Sci U S A 106(47):20051\u201320056","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2957_CR45","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.neuron.2011.08.033","volume":"72","author":"LA Volpicelli-Daley","year":"2011","unstructured":"Volpicelli-Daley LA, Luk KC, Patel TP, Tanik SA, Riddle DM, Stieber A et al (2011) Exogenous alpha-synuclein fibrils induce Lewy body pathology leading to synaptic dysfunction and neuron death. Neuron 72:57\u201371","journal-title":"Neuron"},{"issue":"6","key":"2957_CR46","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.3233\/JPD-240228","volume":"14","author":"AL Woerman","year":"2024","unstructured":"Woerman AL, Luk KC (2024) Are preformed fibrils a model of Parkinson\u2019s disease? J Parkinsons Dis 14(6):1095\u20131103","journal-title":"J Parkinsons Dis"},{"issue":"3","key":"2957_CR47","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1007\/s00401-022-02403-w","volume":"143","author":"SAM Holec","year":"2022","unstructured":"Holec SAM, Liu SL, Woerman AL (2022) Consequences of variability in alpha-synuclein fibril structure on strain biology. Acta Neuropathol 143(3):311\u2013330","journal-title":"Acta Neuropathol"},{"key":"2957_CR48","doi-asserted-by":"publisher","DOI":"10.1101\/2025.06.03.657690","author":"RWL So","year":"2025","unstructured":"So RWL, Frieg B, Camino JD, Silver NRG, Mao A, Stuart E et al (2025) Stochastic misfolding drives the emergence of distinct \u03b1-Synuclein strains. bioRxiv. https:\/\/doi.org\/10.1101\/2025.06.03.657690","journal-title":"bioRxiv"},{"key":"2957_CR49","doi-asserted-by":"crossref","unstructured":"Bartz JC (2017) Prion strain diversity. In: Prusiner SB (ed). Prion Diseases. Cold Spring Harb Perspect Med. Cold Spring Harbor. Cold Spring Harbor Laboratory Press, NY, 31\u201344","DOI":"10.1101\/cshperspect.a024349"},{"issue":"7","key":"2957_CR50","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1016\/j.tins.2024.05.004","volume":"47","author":"AL Woerman","year":"2024","unstructured":"Woerman AL, Bartz JC (2024) Effect of host and strain factors on \u03b1-synuclein prion pathogenesis. Trends Neurosci 47(7):538\u2013550","journal-title":"Trends Neurosci"},{"key":"2957_CR51","doi-asserted-by":"publisher","first-page":"11858","DOI":"10.1128\/JVI.79.18.11858-11863.2005","volume":"79","author":"JC Bartz","year":"2005","unstructured":"Bartz JC, Dejoia C, Tucker T, Kincaid AE, Bessen RA (2005) Extraneural prion neuroinvasion without lymphoreticular system infection. J Virol 79:11858\u201311863","journal-title":"J Virol"},{"issue":"2","key":"2957_CR52","doi-asserted-by":"publisher","first-page":"303","DOI":"10.3233\/JPD-171248","volume":"8","author":"NK Polinski","year":"2018","unstructured":"Polinski NK, Volpicelli-Daley LA, Sortwell CE, Luk KC, Cremades N, Gottler LM et al (2018) Best practices for generating and using Alpha-Synuclein pre-formed fibrils to model Parkinson\u2019s disease in rodents. J Parkinsons Dis 8(2):303\u2013322","journal-title":"J Parkinsons Dis"},{"issue":"5","key":"2957_CR53","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/S1474-4422(23)00109-6","volume":"22","author":"A Siderowf","year":"2023","unstructured":"Siderowf A, Concha-Marambio L, Lafontant DE, Farris CM, Ma Y, Urenia PA et al (2023) Assessment of heterogeneity among participants in the Parkinson\u2019s Progression Markers Initiative cohort using alpha-synuclein seed amplification: a cross-sectional study. Lancet Neurol 22(5):407\u2013417","journal-title":"Lancet Neurol"},{"issue":"2","key":"2957_CR54","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1001\/jamaneurol.2016.4547","volume":"74","author":"M Shahnawaz","year":"2017","unstructured":"Shahnawaz M, Tokuda T, Waragai M, Mendez N, Ishii R, Trenkwalder C et al (2017) Development of a biochemical diagnosis of Parkinson disease by detection of alpha-synuclein misfolded aggregates in cerebrospinal fluid. JAMA Neurol 74(2):163\u2013172","journal-title":"JAMA Neurol"},{"issue":"2","key":"2957_CR55","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1093\/brain\/awab431","volume":"145","author":"I Poggiolini","year":"2022","unstructured":"Poggiolini I, Gupta V, Lawton M, Lee S, El-Turabi A, Querejeta-Coma A et al (2022) Diagnostic value of cerebrospinal fluid alpha-synuclein seed quantification in synucleinopathies. Brain 145(2):584\u2013595","journal-title":"Brain"},{"issue":"4","key":"2957_CR56","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1038\/s41596-022-00787-3","volume":"18","author":"L Concha-Marambio","year":"2023","unstructured":"Concha-Marambio L, Pritzkow S, Shahnawaz M, Farris CM, Soto C (2023) Seed amplification assay for the detection of pathologic alpha-synuclein aggregates in cerebrospinal fluid. Nat Protoc 18(4):1179\u20131196","journal-title":"Nat Protoc"},{"key":"2957_CR57","doi-asserted-by":"publisher","first-page":"RP92775","DOI":"10.7554\/eLife.92775.3","volume":"13","author":"SS Lee","year":"2024","unstructured":"Lee SS, Civitelli L, Parkkinen L (2024) Brain-derived and in vitro-seeded alpha-synuclein fibrils exhibit distinct biophysical profiles. Elife 13:RP92775","journal-title":"Elife"},{"issue":"1","key":"2957_CR58","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s40478-019-0733-3","volume":"7","author":"J-S Dhillon","year":"2019","unstructured":"Dhillon J-S, Trejo-Lopez JA, Riffe C, Levites Y, Sacino AN, Borchelt DR et al (2019) Comparative analyses of the in vivo induction and transmission of \u03b1-synuclein pathology in transgenic mice by MSA brain lysate and recombinant \u03b1-synuclein fibrils. Acta Neuropathol Commun 7(1):80","journal-title":"Acta Neuropathol Commun"},{"key":"2957_CR59","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1146\/annurev-biochem-061516-045115","volume":"86","author":"F Chiti","year":"2017","unstructured":"Chiti F, Dobson CM (2017) Protein misfolding, amyloid formation, and human disease: a summary of progress over the last decade. Annu Rev Biochem 86:27\u201368","journal-title":"Annu Rev Biochem"},{"issue":"7","key":"2957_CR60","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/s41580-019-0101-y","volume":"20","author":"MS Hipp","year":"2019","unstructured":"Hipp MS, Kasturi P, Hartl FU (2019) The proteostasis network and its decline in ageing. Nat Rev Mol Cell Biol 20(7):421\u2013435","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2957_CR61","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1016\/S0140-6736(04)17103-1","volume":"364","author":"MC Chartier-Harlin","year":"2004","unstructured":"Chartier-Harlin MC, Kachergus J, Roumier C, Mouroux V, Douay X, Lincoln S et al (2004) Alpha-synuclein locus duplication as a cause of familial Parkinson\u2019s disease. Lancet 364:1167\u20131169","journal-title":"Lancet"},{"key":"2957_CR62","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1126\/science.1090278","volume":"302","author":"AB Singleton","year":"2003","unstructured":"Singleton AB, Farrer M, Johnson J, Singleton A, Hague S, Kachergus J et al (2003) \u03b1-synuclein locus triplication causes Parkinson\u2019s disease. Science 302:841","journal-title":"Science"}],"container-title":["Acta Neuropathologica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-025-02957-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00401-025-02957-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-025-02957-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T17:14:23Z","timestamp":1762881263000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00401-025-02957-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,8]]},"references-count":62,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2957"],"URL":"https:\/\/doi.org\/10.1007\/s00401-025-02957-5","relation":{},"ISSN":["1432-0533"],"issn-type":[{"value":"1432-0533","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,8]]},"assertion":[{"value":"17 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 November 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 November 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"A.L.W. is a member of Acta Neuropathologica\u2019s Editorial Board. They were not involved in the assessment or decision-making process for this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"50"}}